Search research articles
Contact Us
Filters
Showing results (181-190 of 265) with videos related to
Page
of 27
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 3, 2022
S1 Guidelines for the Kaposi Sarcoma
Stefan Esser, Helmut Schöfer, Christian Hoffmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 17, 2022
S1-Leitlinie: Kaposi-Sarkom
Stefan Esser, Helmut Schöfer, Christian Hoffmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 18, 2020
Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
The British Journal of Dermatology
|
July 27, 2025
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma - clinical activity and safety results from AliCe, a single-arm, multicentre phase 2 DeCOG trial
Jürgen C Becker, Anja H Gesierich, Ulrike Leiter, et al.
Cancers
|
May 14, 2022
Genetic and Clinical Characteristics of <i>ARID1A</i> Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival
Carl Maximilian Thielmann, Johanna Matull, Sebastian Roth, et al.
International Journal of Cancer
|
March 15, 2026
Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study
Ralf Gutzmer, Michael Weichenthal, Thomas Eigentler, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2021
Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology Group
Imke Grimmelmann, Michael Momma, Lisa Zimmer, et al.
Journal for Immunotherapy of Cancer
|
September 24, 2025
Tertiary lymphoid structures in Merkel cell carcinoma facilitate naïve and central memory T-cell infiltration linked to immunotherapy response
Nalini Srinivas, Ivelina Spassova, Kuan Cheok Lei, et al.
Frontiers in Immunology
|
January 1, 2026
Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patients
Carl Maximilian Thielmann, Johanna Andrea Seier, Lisa Schielke, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 14, 2025
Clinical course of Merkel cell carcinoma: A DeCOG multicenter study of 1049 patients
Georg C Lodde, Ulrike Leiter, Anja Gesierich, et al.
Page
of 27
Search research articles
Search
Showing results (181-190 of 265) with videos related to
Sort By:
Page
of 27
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 3, 2022
S1 Guidelines for the Kaposi Sarcoma
Stefan Esser, Helmut Schöfer, Christian Hoffmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 17, 2022
S1-Leitlinie: Kaposi-Sarkom
Stefan Esser, Helmut Schöfer, Christian Hoffmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 18, 2020
Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
The British Journal of Dermatology
|
July 27, 2025
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma - clinical activity and safety results from AliCe, a single-arm, multicentre phase 2 DeCOG trial
Jürgen C Becker, Anja H Gesierich, Ulrike Leiter, et al.
Cancers
|
May 14, 2022
Genetic and Clinical Characteristics of <i>ARID1A</i> Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival
Carl Maximilian Thielmann, Johanna Matull, Sebastian Roth, et al.
International Journal of Cancer
|
March 15, 2026
Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study
Ralf Gutzmer, Michael Weichenthal, Thomas Eigentler, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2021
Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology Group
Imke Grimmelmann, Michael Momma, Lisa Zimmer, et al.
Journal for Immunotherapy of Cancer
|
September 24, 2025
Tertiary lymphoid structures in Merkel cell carcinoma facilitate naïve and central memory T-cell infiltration linked to immunotherapy response
Nalini Srinivas, Ivelina Spassova, Kuan Cheok Lei, et al.
Frontiers in Immunology
|
January 1, 2026
Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patients
Carl Maximilian Thielmann, Johanna Andrea Seier, Lisa Schielke, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 14, 2025
Clinical course of Merkel cell carcinoma: A DeCOG multicenter study of 1049 patients
Georg C Lodde, Ulrike Leiter, Anja Gesierich, et al.
Page
of 27